| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -22,5 k € | +86.5% | -166,7 k € | +36.0% | -260,6 k € | +61.4% | -674,7 k € | -10.2% | -612,4 k € | +9.5% | -676,7 k € | +15.6% | -801,7 k € | -28.7% | -622,8 k € | +4.9% | -654,6 k € | +33.2% | -979,8 k € | +0.2% | -981,9 k € | +0.1% | -982,5 k € | -0.3% | -979,3 k € | +0.5% | -983,8 k € | +4.6% | -1,0 M € | |
| EBITDA | -27,5 k € | +83.6% | -167,7 k € | +35.9% | -261,6 k € | +61.3% | -675,5 k € | -10.2% | -613,3 k € | +9.5% | -677,6 k € | +15.6% | -802,5 k € | -28.7% | -623,6 k € | +4.9% | -655,5 k € | +33.2% | -980,7 k € | +0.2% | -982,8 k € | +0.1% | -983,3 k € | -0.3% | -980,2 k € | +0.4% | -984,1 k € | +4.6% | -1,0 M € | |
| Operating profit | -27,5 k € | +83.6% | -167,7 k € | +35.9% | -261,6 k € | +61.3% | -675,5 k € | -10.2% | -613,3 k € | +9.5% | -677,6 k € | +15.6% | -802,5 k € | -28.7% | -623,6 k € | +4.9% | -655,5 k € | +33.2% | -980,7 k € | +0.2% | -982,8 k € | +0.1% | -983,3 k € | -0.3% | -980,2 k € | +0.4% | -984,1 k € | +4.6% | -1,0 M € | |
| Profit/loss | -8,4 M € | -29.8% | -6,5 M € | -170.9% | 9,1 M € | +84.9% | 4,9 M € | +58.6% | 3,1 M € | +570.9% | 464,1 k € | -88.8% | 4,2 M € | +175.8% | -5,5 M € | -125.8% | 21,3 M € | +317.5% | -9,8 M € | -1013.3% | -880,0 k € | -4534.9% | 19,8 k € | +100.9% | -2,2 M € | -28.5% | -1,7 M € | -70.4% | -1,0 M € | |
| Equity | 15,4 M € | -28.1% | 21,5 M € | -34.3% | 32,7 M € | +16.8% | 28,0 M € | +44.7% | 19,3 M € | +12.0% | 17,3 M € | -3.0% | 17,8 M € | +10.1% | 16,2 M € | -21.8% | 20,7 M € | +1.7% | 20,3 M € | -11.4% | 22,9 M € | +33.3% | 17,2 M € | +75.9% | 9,8 M € | +25.4% | 7,8 M € | -18.0% | 9,5 M € | |
| Total assets | 15,5 M € | -28.2% | 21,6 M € | -34.2% | 32,8 M € | +17.0% | 28,0 M € | +44.7% | 19,4 M € | +11.9% | 17,3 M € | -2.9% | 17,8 M € | +9.0% | 16,3 M € | -21.0% | 20,7 M € | +1.7% | 20,3 M € | -11.4% | 23,0 M € | +33.3% | 17,2 M € | +75.8% | 9,8 M € | +25.4% | 7,8 M € | -18.0% | 9,5 M € | |
| Cash | 1,9 M € | -35.3% | 3,0 M € | +177.3% | 1,1 M € | -14.5% | 1,3 M € | +11.1% | 1,1 M € | -23.6% | 1,5 M € | +8.7% | 1,4 M € | +47.8% | 926,1 k € | -77.0% | 4,0 M € | +152.8% | 1,6 M € | +9.0% | 1,5 M € | +8.0% | 1,4 M € | +428.6% | 256,2 k € | -81.3% | 1,4 M € | -74.4% | 5,3 M € | |
| Debts | 93,5 € | -83.5% | 566,2 € | -98.3% | 33,3 k € | +67167.9% | 49,5 € | 0.0% | 49,5 € | +297.9% | 12,5 € | +730.0% | 1,5 € | -100.0% | 150,8 k € | — | — | 3,8 k € | — | 2,3 k € | — | — | ||||||||
Public limited company · Leuven · incorporated on 26/02/2010
Company — Voluntary dissolution - liquidation.
Public limited company loss-making in the latest fiscal year. Cash position declining (-35.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
CAPRICORN HEALTH-TECH FUND is a Public limited company incorporated in 2010. Its registered office is in Leuven.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette